Viewing Study NCT00416312


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2025-12-26 @ 11:07 AM
Study NCT ID: NCT00416312
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2006-12-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: